ID | 115042 |
著者 |
Okusha, Yuka
Okayama University|Harvard Medical School
Eguchi, Takanori
Okayama University
Tran, Manh T.
Okayama University
Sogawa, Chiharu
Okayama University
Itagaki, Mami
Okayama University
Taha, Eman A.
Okayama University|Ain Shams University
Ono, Kisho
Okayama University
Aoyama, Eriko
Okayama University
Kozaki, Ken-ichi
Okayama University
Calderwood, Stuart K.
Harvard Medical School
Takigawa, Masaharu
Okayama University
Okamoto, Kuniaki
Okayama University
|
キーワード | matrix metalloproteinase
moonlighting metalloproteinase (MMP)
protein moonlighting
transcription factor
extracellular vesicles
oncosome
genome editing
CRISPR
cellular communication network factor
CCN2/CTGF
|
資料タイプ |
学術雑誌論文
|
抄録 | Matrix metalloproteinase 3 (MMP3) plays multiple roles in extracellular proteolysis as well as intracellular transcription, prompting a new definition of moonlighting metalloproteinase (MMP), according to a definition of protein moonlighting (or gene sharing), a phenomenon by which a protein can perform more than one function. Indeed, connective tissue growth factor (CTGF, aka cellular communication network factor 2 (CCN2)) is transcriptionally induced as well as cleaved by MMP3. Moreover, several members of the MMP family have been found within tumor-derived extracellular vesicles (EVs). We here investigated the roles of MMP3-rich EVs in tumor progression, molecular transmission, and gene regulation. EVs derived from a rapidly metastatic cancer cell line (LuM1) were enriched in MMP3 and a C-terminal half fragment of CCN2/CTGF. MMP3-rich, LuM1-derived EVs were disseminated to multiple organs through body fluid and were pro-tumorigenic in an allograft mouse model, which prompted us to define LuM1-EVs as oncosomes in the present study. Oncosome-derived MMP3 was transferred into recipient cell nuclei and thereby trans-activated the CCN2/CTGF promoter, and induced CCN2/CTGF production in vitro. TRENDIC and other cis-elements in the CCN2/CTGF promoter were essential for the oncosomal responsivity. The CRISPR/Cas9-mediated knockout of MMP3 showed significant anti-tumor effects such as the inhibition of migration and invasion of tumor cells, and a reduction in CCN2/CTGF promoter activity and fragmentations in vitro. A high expression level of MMP3 or CCN2/CTGF mRNA was prognostic and unfavorable in particular types of cancers including head and neck, lung, pancreatic, cervical, stomach, and urothelial cancers. These data newly demonstrate that oncogenic EVs-derived MMP is a transmissive trans-activator for the cellular communication network gene and promotes tumorigenesis at distant sites.
|
掲載誌名 |
Cancers
|
ISSN | 20726694
|
出版者 | MDPI
|
巻 | 12
|
号 | 4
|
開始ページ | 881
|
発行日 | 2020-04-04
|
権利情報 | © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
|
EDB ID | |
出版社版DOI | |
出版社版URL | |
フルテキストファイル | |
言語 |
eng
|
著者版フラグ |
出版社版
|
部局 |
歯学系
|